| Hiv and Lymphoma: from Epidemiology to Clinical Management |
12 |
| In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation |
11 |
| Severe Liver Iron Concentrations (LIC) in 24 Patients with beta-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications |
11 |
| Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver |
11 |
| Human Herpesvirus 8 and Lymphoproliferative Disorders |
10 |
| Light Chain Amyloidosis |
9 |
| The Broad-Ranging Panorama of Systemic Autoinflammatory Disorders with Specific Focus on Acute Painful Symptoms and Hematologic Manifestations in Children |
9 |
| Detection of beta-Thalassemia Carriers by Red Cell Parameters Obtained from Automatic Counters using Mathematical Formulas |
8 |
| Jadenu (R) Substituting Exjade (R) in Iron Overloaded beta-Thalassemia Major (BTM ) Patients: A Preliminary Report of the Effects on the Tolerability, Serum Ferritin Level, Liver Iron Concentration and Biochemical Profiles |
8 |
| Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans |
8 |
| Breastfeeding in Patients with Chronic Myeloid Leukaemia: Case Series with Measurements of Drug Concentrations in Maternal Milk and Literature Review |
7 |
| Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies |
7 |
| Curing Hemoglobinopathies: Challenges and Advances of Conventional and New Gene Therapy Approaches |
6 |
| Direct Oral Anticoagulants in Patients Affected by Major Congenital Thrombophilia |
6 |
| Sickle Cell Disease and Pregnancy |
6 |
| Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling |
6 |
| Role of Cytokines as Molecular Marker of Dengue Severity |
5 |
| Pregnancy in Thalassemia |
5 |
| Bone Mineral Density and Vitamin D Receptor Genetic Variants in Egyptian Children with Beta Thalassemia Major on Vitamin D Supplementation |
5 |
| Economic Evaluation of Chelation Regimens for beta-Thalassemia Major: a Systematic Review |
5 |
| Epidemiology of Malaria in the State of Qatar, 2008-2015 |
5 |
| Final Height and Endocrine Complications in Patients with beta-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content |
5 |
| Perioperative Management of Sickle Cell Disease |
5 |
| Prevalence of beta-Thalassemia Mutations among Northeastern Iranian Population and their Impacts on Hematological Indices and Application of Prenatal Diagnosis, a Seven-Years Study |
4 |
| Successful Management of Kaposiform Hemangioendothelioma with Long-Term Sirolimus Treatment: a Case Report and Review of the Literature |
4 |
| Soluble ST2 and CD163 as Potential Biomarkers to Differentiate Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome |
4 |
| Gut Colonization with Carbapenem-resistant Enterobacteriaceae Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of A Prospective Surveillance Study |
4 |
| Molecular Analysis of Non-Transfusion Dependent Thalassemia Associated with Hemoglobin E-beta-Thalassemia Disease without alpha-Thalassemia |
4 |
| Outbreak of Burkholderia Cepacia Infection: a Systematic Study in a Hematolooncology Unit of a Tertiary Care Hospital from Eastern India |
4 |
| Iron Toxicity and Hemopoietic Cell Transplantation: Time to Change the Paradigm |
4 |
| Novel Deleterious Sequence Change in the NLRP12 Gene in a Child with the Autoinflammatory Syndrome, Joint Hypermobility and Cutis Laxa from India |
3 |
| Adult Sickle Cell Anaemia Patients in Bone Pain Crisis have Elevated Pro-Inflammatory Cytokines |
3 |
| West Nile Virus Encephalitis in Haematological Setting: Report of Two Cases and a Brief Review of the Literature |
3 |
| Seroprevalence of Toxocara Canis in the city of Catania, Italy |
3 |
| Thyroid Disorders in Homozygous beta-Thalassemia: Current Knowledge, Emerging Issues and Open Problems |
3 |
| The Emerging Resistance in Nosocomial Urinary Tract Infections: From the Pediatrics Perspective |
3 |
| Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs |
3 |
| Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update |
3 |
| Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso |
3 |
| Increase in Candida Parapsilosis Candidemia in Cancer Patients |
3 |
| New Therapeutic Options for the Treatment of Sickle Cell Disease |
3 |
| Respiratory Viral Infections in Children and Adolescents with Hematological Malignancies |
3 |
| Thrombocytopenia in Patients with Myelodysplastic Syndromes: Still an Unsolved Problem |
3 |
| Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients |
3 |
| Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature |
2 |
| Infections in Myelodysplastic Syndrome in Relation to Stage and Therapy |
2 |
| Evaluation of Polymyxin B Susceptibility Profile and Detection of Drug Resistance Genes among Acinetobacter Baumannii Clinical Isolates in Tehran, Iran during 2015-2016 |
2 |
| The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A Longitudinal, Prospective Study |
2 |
| Detection of CALR Mutations Using High Resolution Melting Curve Analysis (HRM-A); Application on a Large Cohort of Greek ET and MF Patients |
2 |
| Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India |
2 |
